Study S003260

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Multi-Center Study to Evaluate the Efficacy and Safety of TTP273 Following 12 Weeks Administration in Subjects With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

ClinicalTrials.gov record

Registration

Registration: NCT02653599
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: COMPLETED
Enrollment: 174
Start: 2015-12
Primary completion: 2016-11
Lead sponsor: vTv Therapeutics
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:TTP273; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Change in HbA1c from baseline at 12 weeks [Day 1 to Week 12]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.